pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
vemzatatug vedotin
vemzatatug vedotin[INN]
Refractory Multiple Myeloma
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
venadaparib
venadaparib [INN]
Gastric Cancer
Idience Co Ltd
0 catalysts
Phase 2
vepafestinib
vepafestinib [INN]
Non-Small Cell Lung Cancer
Helsinn Healthcare SA
0 catalysts
Phase 2
← prev
page 49 of 50
next →
131
Pain89
Neurology1
verekitug
Nasal Polyps (Nasal Polyposis)
$UPBUpstream Bio, Inc.
0 catalysts
Phase 2
vididencel
vididencel [INN]
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Mendus AB
0 catalysts
Phase 2
vilastobart
Cervical Cancer
$XLOXilio Therapeutics, Inc.
0 catalysts
Phase 2
vilobelimab
Gohibic (vilobelimab)
Acute Respiratory Distress Syndrome
Complement C5
InflaRx NV
0 catalysts
Phase 2
vinorelbine tartrate
Vinorelbine Tartrate (vinorelbine tartrate)
Soft Tissue Sarcoma
Tubulin
Taiwan Liposome Co Ltd
0 catalysts
Phase 2
visepegenatide
visepegenatide [INN]
Type 2 Diabetes
PegBio Co Ltd
0 catalysts
Phase 2
visugromab
Metastatic Hepatocellular Carcinoma (HCC)
Catalym GmbH
0 catalysts
Phase 2
vocacapsaicin hydrochloride
Post-Operative Pain
Concentric Analgesics Inc
0 catalysts
Phase 2
vodobatinib
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Tyrosine-protein kinase ABL1Bcr/Abl fusion protein
Sun Pharma Advanced Research Company Ltd
0 catalysts
Phase 2
volagidemab
Type 1 Diabetes (Juvenile Diabetes)
Glucagon receptor
Remd Biotherapeutics Inc
0 catalysts
Phase 2
volixibat potassium
Pruritus
$MIRMMirum Pharmaceuticals, Inc.
0 catalysts
Phase 2
vonafexor
vonafexor [INN]
Alport Syndrome
Enyo Pharma SA
0 catalysts
Phase 2
vopimetostat
vopimetostat [INN]
Bladder Cancer
$TNGXTango Therapeutics, Inc.
0 catalysts
Phase 2
voretigene neparvovec
Luxturna (voretigene neparvovec-rzyl)
Choroideremia
Retinoid isomerohydrolase
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
vosilasarm
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Ellipses Pharma Ltd
0 catalysts
Phase 2
vusolimogene oderparepvec
Basal Cell Carcinoma (Basal Cell Epithelioma)
$REPLReplimune Group, Inc.
0 catalysts
Phase 2
xelafaslatide
Retinal Pigment Epithelial (RPE) Detachment
ONL Therapeutics Inc
0 catalysts
Phase 2
zabilugene almadenorepvec
Pancreatic Ductal Adenocarcinoma
$TOVXTheriva Biologics, Inc.
0 catalysts
Phase 2
zagociguat
MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-L…
Tisento Therapeutics Inc
0 catalysts
Phase 2
zalifrelimab
Cervical Cancer
Cytotoxic T-lymphocyte protein 4
$AGENAGENUS INC
0 catalysts
Phase 2
zaltenibart
Paroxysmal Nocturnal Hemoglobinuria
Novo Nordisk AS
0 catalysts
Phase 2
zampilimab
zampilimab [INN]
Idiopathic Pulmonary Fibrosis
Chiesi Farmaceutici SpA
0 catalysts
Phase 2
zegocractin
Pancreatitis
$CALCCalciMedica, Inc.
0 catalysts
Phase 2
zeleciment basivarsen
Myotonic Dystrophy
$DYNDyne Therapeutics, Inc.
0 catalysts
Phase 2
zeleciment rostudirsen
Duchenne Muscular Dystrophy
$DYNDyne Therapeutics, Inc.
0 catalysts
Phase 2
zelenirstat
zelenirstat [INN]
Refractory Acute Myeloid Leukemia
Pacylex Pharmaceuticals Inc
0 catalysts
Phase 2
zelicapavir
Respiratory Syncytial Virus (RSV) Infections
$ENTAENANTA PHARMACEUTICALS INC
0 catalysts